Conditions: Urinary Tract Infection Vesicoureteral Reflux
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 10
Healthy volunteers: yes

Brief summary:
The study will be evaluating the efficacy and safety of a contrast drug in pediatric renal ultrasound.

Detailed description:

Arms:
arm 1: All subjects will be recruited into this arm. All subjects will receive 0.03 ml/kg IV sulfur hexafluoride type-a lipid microspheres one time, unless a second, adjusted dose is necessary.

Interventions: intervention 1: Sulfur hexafluoride type-a lipid microspheres
Intervention descriptions: intervention 1: Used as a contrast to enhance renal ultrasound

Protocol document: